- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05956366
Effectiveness of Family-based Intervention for Youn Persons With Eating Disorders (VIBUS-wp1)
Effectiveness of Family-based Intervention in a Child and Adolescent Mental Health Service for Children and Adolescents With Eating Disorders
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The overall aim is to assess associations between patient characteristics and treatment response across the spectrum of eating disorders to identify, which patients benefit from family based treatment, and which patients possibly would need other kinds of treatment or more intensive care.
Research questions:
- Which patient and family characteristics predict faster recovery from ED in childhood and adolescence?
- Which patient and family characteristics predict intensification of treatment in the forms of day hospital or full hospitalization?
- At which time point can recovery be predicted based on information from initial assessment and/or assessment during the course of treatment?
- Which patient and family characteristics (e.g. patterns of comorbid symptoms) are common in those not responding well to treatment within each diagnostic category?
- How many young patients migrate between ED diagnoses, and what characterizes these patients?
Studies on treatment effectiveness for EDNOS in children and adolescents are still lacking. Hence, an important research question of this study is whether family based treatment for EDNOS is effective and is perceived as helpful by patients and families?
In addition, the project will seek to answer the following:
- Is treatment effectiveness in The Capital Region of Denmark (BUC) comparable to published results from other countries in the same age group?
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mette Bentz, PhD
- Phone Number: +45 38 64 10 35
- Email: mette.bentz@regionh.dk
Study Locations
-
-
-
Copenhagen, Denmark, DK-2400
- Recruiting
- Child and Adolescent Mental Health Care Center
-
Contact:
- Mette Bentz, PhD
- Phone Number: +45 38 64 10 35
- Email: mette.bentz@regionh.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
All patients assessed and treated for any eating disorder (ICD-10: F50.0-F50.8) in the unit for treatment of eating disorders will be invited to participate.
Due to the naturalistic design of this study we will examine a representative, consecutive sample, without any exclusion criteria except the absence of informed consent by patient and parents or legal care takers.
Description
Inclusion Criteria:
- begin treatment for eating disorder
Exclusion Criteria:
- lack of informed consent
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Anorexia nervosa
Children and adolescents presenting for treatment for anorexia nervosa typica or atypica (ICD-10: F50.0 or F50.1)
|
Open-end family therapy ad modum The Maudsley model
Other Names:
|
|
Bulimia nervosa
Children and adolescents presenting for treatment for bulimia nervosa typica or atypica (ICD-10: F50.2 or F50.3)
|
Open-end family therapy ad modum The Maudsley model
Other Names:
|
|
Other eating disorders
Children and adolescents presenting for treatment for other eating disorders (ICD-10: F50.8)
|
Open-end family therapy ad modum The Maudsley model
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
proportion of participants with weight normalisation
Time Frame: through treatment completion an average of 1 year
|
at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory.
BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents
|
through treatment completion an average of 1 year
|
|
proportion of participants with weight normalisation
Time Frame: 2.5 years after treatment completion
|
at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory.
BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents
|
2.5 years after treatment completion
|
|
proportion of participants with weight normalisation
Time Frame: 5 years after treatment completion
|
at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory.
BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents
|
5 years after treatment completion
|
|
proportion of participants with weight normalisation
Time Frame: 7.5 years after treatment completion
|
at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory.
BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents
|
7.5 years after treatment completion
|
|
proportion of participants with weight normalisation
Time Frame: 10 years after treatment completion
|
at or above 95% of ideal BMI adjusted for age and gender, based on the individual´s prior growth trajectory.
BMI is calculated as weight in kg/(height in meters*height in meters), and percentage if ideal BMI adjusted for age and gender is based on published, standardized growth curves from Danish children and adolescents
|
10 years after treatment completion
|
|
proportion of participants with absence of eating disordered behaviors
Time Frame: through treatment completion an average of 1 year
|
absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).
|
through treatment completion an average of 1 year
|
|
proportion of participants with absence of eating disordered behaviors
Time Frame: 2.5 years after treatment completion
|
absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).
|
2.5 years after treatment completion
|
|
proportion of participants with absence of eating disordered behaviors
Time Frame: 5 years after treatment completion
|
absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).
|
5 years after treatment completion
|
|
proportion of participants with absence of eating disordered behaviors
Time Frame: 7.5 years after treatment completion
|
absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).
|
7.5 years after treatment completion
|
|
proportion of participants with absence of eating disordered behaviors
Time Frame: 10 years after treatment completion
|
absence for 4 weeks (according to diagnostic questions if Eating Disorder Examination (EDE).
|
10 years after treatment completion
|
Collaborators and Investigators
Investigators
- Principal Investigator: Mette Bentz, PhD, Child and Adolescent Mental Health Care Centre, Capital Region of Denmark
- Study Director: Anne Katrine Pagsberg, professor, Child and Adolescent Mental Health Care Centre, Capital Region of Denmark
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-17022391
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eating Disorders
-
Ibn Haldun UniversityCompletedDisordered Eating Behaviors | Eating Pathology | Eating Disorders SymptomsTurkey
-
Ibn Haldun UniversityActive, not recruitingDisordered Eating Behaviors | Eating Pathology | Eating Disorder SymptomsTurkey
-
Axsome Therapeutics, Inc.Enrolling by invitationBinge-Eating DisorderUnited States
-
BioprojetCompleted
-
University of PalermoUniversity of Padova; University of CatanzaroRecruitingEating Disorders | Eating Behavior | Eating Disorder SymptomItaly
-
Ali RezaiActive, not recruiting
-
Axsome Therapeutics, Inc.RecruitingBinge-Eating DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBinge-Eating DisorderUnited States
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
-
Bezmialem Vakif UniversityMuğla Sıtkı Koçman University; The Scientific and Technological Research Council... and other collaboratorsActive, not recruitingEating Disorders | Eating Behavior | Orthodontic Appliance Complication | Eating HabitTurkey
Clinical Trials on Family-based treatment
-
Mayo ClinicNational Institute of Mental Health (NIMH)Enrolling by invitationEating DisordersUnited States
-
Mayo ClinicCompletedMood Disorders in Children and AdolescentsUnited States
-
New York State Psychiatric InstituteCompletedAnorexia Nervosa
-
University of PittsburghNational Institutes of Health (NIH)CompletedBehavior
-
Stanford UniversityUniversity of ChicagoCompleted
-
Helsinki University Central HospitalCompletedEating Disorders
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Stanford UniversityMcMaster UniversityCompletedAnorexia NervosaUnited States, Canada
-
University of PittsburghNational Institute of Mental Health (NIMH); Lifespan; Rhode Island CollegeActive, not recruitingAnorexia Nervosa | Eating DisordersUnited States
-
University Hospital, AkershusRådgivning om SpiseforstyrrelserTerminatedAnorexia Nervosa | Atypical Anorexia NervosaNorway